| Tag | Content |
|---|
EnhancerAtlas ID | HS091-20225 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr17:47811950-47813750 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr17:47812368-47812389 | GGAGGAGGGGGAGTAGGAGTT | + | 6.01 | | ZNF263 | MA0528.1 | chr17:47812365-47812386 | GGAGGAGGAGGGGGAGTAGGA | + | 9.11 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_09635 | chr17:47811558-47821132 | CD14 | | SE_11169 | chr17:47811709-47828655 | CD20 | | SE_13338 | chr17:47812542-47826782 | CD34_Primary_RO01536 | | SE_14060 | chr17:47812766-47821004 | CD34_Primary_RO01549 | | SE_16129 | chr17:47812742-47813474 | CD4_Naive_Primary_7pool | | SE_17895 | chr17:47811998-47821059 | CD4p_CD25-_CD45ROp_Memory | | SE_22323 | chr17:47811774-47820951 | CD8_primiary | | SE_58642 | chr17:47800624-47842648 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH17I049734 | chr17 | 47812163 | 47812490 | | GH17I049735 | chr17 | 47812790 | 47828368 |
|
Enhancer Sequence | CTCAAAAAAT AAATAAATAA AAATAAAAAT TAAAAAAAAT AAAAAGACAC TAAAAGGTTG 60
GCAGTTCCTC AAAAAGTGAA ACATAGAATT ACCATATGAC CCAGCAGTTC CACTCCTAGG 120
TATATACCAA CAAAGAACCG AAAGCAGGGA CTTGAAGCAT TTTTCACAAT AGCCAAAAGG 180
TGGGAGCAAC CCGAGCATCC ACGAATGGAG AAACGGATAA ACAAATGCAG CACATCCATA 240
CTGTGGAATA CTATTCAGTC TTCAAAAGGA AGGCAATTCT GACACACACT CCAATACAGA 300
TGATGCTGAG TTAAGTAAGC AAGACAAAAG GACAAATATT CTGTTTTTCT TGAGGTATCT 360
AGAATAGGCA AATTCATAGG GACAAAAAAA TAGAATAGAC TTTACCAAGG GCTTAGGAGG 420
AGGAGGGGGA GTAGGAGTTA TTGTTTAATG GATACACAGT CTCTGTTTGA GATGATGAAA 480
TTCAGGTTGT GGAAATGGAC CCTGGTTATG GTTGCACAAC ATTGTAAATG TATGTAATGC 540
CAGTGAACAT AAGCTTTTAT GGTTAAAATA GTGAGTATAT ATTTTACTAC AATAAAAAAA 600
AGGACACTAA CTGACCAATA TGGTGAAACC TCATCTACTA AAAATGCAAA AATTAGCCGG 660
GCGTGGTGGT GCACACCTGT AATCCCAGCT ACTTGGGAGG CTGAGACAGG AGAATTGCTT 720
GAACCCGGGA AGCGGAGGCT GCAGTGAGGT GAGATCACGC CACTGCACTC CAGCCTGGGC 780
AACACAGCAA GACTCCGTCT CAAAAAAAAA AAGACACTAA CAATACTACC TCCACTCTCC 840
AAATTCACTG AAGCATTTAC ATACATTTTG CCATAGTTGT AATCAGTAGG AAATATGCTA 900
TATTATGTTC TGCTTGGTTC CACCTATTTC ATATACCTTT TCCCATGTAT TAACAATCTA 960
CATATTTGTT ATTTTAAAAG ACTATATAAT ATTCCTCCAG GTTGATGTAC ACTAGTTTGC 1020
TTAGCCATTC TTGTATTTTT GTCTTTTCTT TTTATTTTTT GAGTCAGGGT CTCACTGTGT 1080
TGCCCAGGCT GGTCTTGAAC TCCTGGGCTC AAGTGATCTT CCTGCCTTGG CCTCCCAAAG 1140
TGCTGGGATT ACAGGCATGA GCCACCACAC CCGACCCATT CCTATATTTT TGAACATTTG 1200
AGGGATTCCT CTCCAATTTG GACATCAAAA ATGTTACTAT ATGGCCAACT TTTACTCTGT 1260
GTTTTTATCT AATCCCTGGC ATAGTTCTAG ATCATTCTCA CTCAGCCATC ATATATGTGC 1320
TTATTTAAAA CAAGTGAATA ATTTATAACT ACAACAGTAG TAAGTGTGAA CTGTAGAAAA 1380
GTCAGGAAAT ATATAAATAT AAACAAACAG AAAAAAACCC TCAACTCTCA ACACCCAGAG 1440
ATAACCAATG TTATGAGAAA TATAAACTTA CAGGTCTTAC CTCTTCTGTG TGTGTGTATG 1500
TGTGTGTGTA TATATACGCT TTACAATTTA AAATGGGATT ATACTGTACG TATTGTTTTG 1560
TTATGTTTTT ACCTTATAAA CATCTTTCCA AATCAATATA TATTGACATA AAACACATCA 1620
TTTTAAATGA TATTAACATT CCTAGGTTAA ACCTCTTCAA AGGCTCTCTT TCTTTTTTTT 1680
TTTTTTGAGA CGGAGTCACG CTTTGTCGCC CAGGCTGGAG TGCAGTGGCA CAAGCTCGGC 1740
TTACTGCAAG CTCCGCCTCC CAGGTTCACA CCATTCTCCT GCCTCAGCCT CCCAAATAAC 1800
|
